Cosmeceuticals

Seminars in Cutaneous Medicine and Surgery

Volumn 25, Issue 3, 2006, Pages 163-168

  Choi, Christine M ^a,b   Berson, Diane S ^a,b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMINOPEPTIDASE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ASCORBIC ACID; COSMETIC; DEANOL; DEXPANTHENOL; FLAVONOID; GROWTH FACTOR; HYDROQUINONE; IDEBENONE; KINETIN; LICOCHALCONE A; LYCOPENE; NICOTINAMIDE; PANTOTHENIC ACID; PEPTIDE; PLACENTA EXTRACT; PLATELET DERIVED GROWTH FACTOR; POLYPHENOL; POLYSACCHARIDE; PYCNOGENOL; RECOMBINANT EPIDERMAL GROWTH FACTOR; RETINOL; SILYMARIN; THIOCTIC ACID; UBIQUINONE; UNINDEXED DRUG; VITAMIN B COMPLEX;

ACNE; CLINICAL TRIAL; HUMAN; HYPERPIGMENTATION; IRRITANT DERMATITIS; LIGHT DAMAGE; OCHRONOSIS; PEMPHIGOID; PRESCRIPTION; REVIEW; SCAR FORMATION; SKIN DISEASE; SKIN INJURY; UNITED STATES; WRINKLE;

COSMETIC TECHNIQUES; COSMETICS; DERMATOLOGIC AGENTS; HUMANS; SKIN AGING;

EID: 33750025050     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sder.2006.06.010     Document Type: Review

References (54)

1. Market Trends: The U.S. Cosmeceuticals and Anti-Aging Products Market. Packaged Facts: A Division of MarketResearch.com. Available at: http://www.packagedfacts.com/; Internet. Accessed July 11, 2006
2. Brody H.J. Relevance of cosmeceuticals to the dermatologic surgeon. Dermatol Surg 31 (2005) 796-798
3. Draelos Z.D. Retinoids in cosmetics. Cosmet Dermatol 18 suppl (2005) 3-5
4. Gensler H.L. Prevention of photoimmunosuppression and photocarcinogenesis by topical nicotinamide. Nutr Cancer 29 (1997) 157-162
5. Bissett D.L., Oblong J.E., and Berge C.A. Niacinamide: A B vitamin that improves aging facial skin appearance. Dermatol Surg 31 (2005) 860-865
6. Bissett D.L., and Oblong J.E. Cosmeceutical Vitamins: Vitamin B. In: Draelos Z.D. (Ed). Cosmeceuticals (2005), Elsevier Saunders, Philadelphia 57-62
7. Farris P.K. Topical vitamin C: a useful agent for treating photoaging and other dermatologic conditions. Dermatol Surg 31 (2005) 814-817
8. Fitzpatrick R.E., and Rostan E.F. Double- blind, half- face study comparing topical vitamin C and vehicle for rejuvenation of photodamage. Dermatol Surg 28 (2002) 231-236
9. Davidson J.M., LuValle P.A., Zoia O., et al. Ascorbate differentially regulates elastin and collagen biosynthesis in vascular smooth muscle cells and skin fibroblasts by pretranslational mechanism. J Biol Chem 272 (1997) 345-352
10. Pinnell S.R. Cutaneous photodamage, oxidative stress, and topical antioxidant protection. J Am Acad Dermatol 48 (2003) 1-19
11. Beitner H. Randomized, placebo- controlled, double blind study on the clinical efficacy of a cream containing 5% alpha- lipoic acid related to photoaging of facial skin. Br J Dermatol 149 (2003) 841-849
12. Hoppe U., Bergemann J., Diembeck W., et al. Coenzyme Q10, a cutaneous antioxidant and energizer. Biofactors 9 (1999) 371-378
13. Burke K.E. Cosmeceutical vitamins: vitamin B. In: Draelos Z.D. (Ed). Cosmeceuticals (2005), Elsevier Saunders, Philadelphia 125-132
14. Sadick N.S. Future cosmeceuticals of dermatologic importance. In: Draelos Z.D. (Ed). Cosmeceuticals (2005), Elsevier Saunders, Philadelphia 199-201
15. Prevage MD: Irvine, Calif. Allergan, Inc.; Available at: http://www.prevagemd.com/x_studies.asp; Internet. Accessed July 11, 2006
16. Khanna S., Roy S., Bagchi D., et al. Upregulation of oxidant-induced VEGF expression in cultured keratinocytes by a grape seed proanthocyanidin extract. Free Radic Biol Med 31 (2001) 38-42
17. Chiu A.E., Chan J.L., Kern D.G., et al. Double- blinded, placebo- controlled trial of green tea extracts in the clinical and histologic appearance of photoaging skin. Dermatol Surg 31 (2005) 855-859
18. Kinerase. Costa Mesa, Calif. Valeant Pharmaceuticals International; Available at: http://www.kinerase.com/sciencecorecollection.html; Internet. Accessed July 11, 2006
19. Fitzpatrick R.E., and Rostan E.F. Reversal of photodamage with topical growth factors: a pilot study. J Cosmet Laser Ther 5 (2003) 25-34
20. TM: Lausanne, Switzerland. Neocutis, Inc.; Available at: http://www.neocutis.com/categories.php?catid=13; Internet. Accessed July 11, 2006
21. Lupo M.P. Cosmeceutical peptides. Dermatol Surg 31 (2005) 832-836
22. Katayama K., Armendariz- Borunda J., Rachow R., et al. A pentapeptide from type I procollagen promotes extracellular matrix production. J Biol Chem 268 (1993) 9941-9944
23. Farris P. Cosmeceutical critique: peptides. Skin & Allergy News 35 (2004) 30
24. Gutierrez L.M., Viniegra S., Rueda J., et al. A peptide that mimics the C-terminal sequence of SNAP-25 inhibits secretory vesicle docking in chromaffin cells. J Biol Chem 272 (1997) 2634-2639
25. R: Norwalk, Conn. Centerchem, Inc.; Available at: http://www.centerchem.com/PDFs/Argireline%202%20Sider.pdf, Internet. Accessed July 11, 2006
26. Grossman R. The role of dimethylaminoethanol in cosmetic dermatology. Am J Clin Dermatol 6 (2005) 39-27
27. Dieck K., Ceilley R.I., Immeyer J., et al. Anti- inflammatory properties of licochalcone A from Glycyrrhiza inflate on various human skin cells (2005), Poster presented at: American Academy of Dermatology, New Orleans, Louisiana February 18-22, (poster 1005)
28. Weber T.M., Scholermann A., Burger A., et al. Tolerance and efficacy of a skin care regimen containing licochalcone A for adults with erythematic rosacea and facial redness (2005), Poster presented at: American Academy of Dermatology, New Orleans, Louisiana February 18-22, (poster 1046)
29. Mohanty N.K., Saxena S., Singh U.P., et al. Lycopene as a chemopreventive agent in the treatment of high- grade prostate intraepithelial neoplasia. Urol Oncol 23 (2005) 383-385
30. Fazekas Z., Gao D., Saldi R.N., et al. Protective effects of lycopene against ultraviolet B- induced photodamage. Nutr Cancer 47 (2003) 181-187
31. Torras M.A., Faura C.A., Schonlau F., et al. Antimicrobial activity of pycnogenol. Phytother Res 19 (1995) 647-648
32. Sime S., and Reeve V.E. Protection from inflammation, immunosuppression and carcinogenesis induced by UV radiation in mice by topical pycnogenol. Photochem Photobiol 9 (2004) 193-198
33. Blazso G., Gabor M., Schonlau F., et al. Pycnogenol accelerates wound healing and reduces scar formation. Phytother Res 18 (2004) 579-581
34. Tixier J.M., Godeau G., Robert A.M., et al. Evidence by in vivo and in vitro studies that binding of pycnogenols to elastin affects its rate of degradation by elastases. Biochem Pharmacol 33 (1984) 3933-3939
35. Saliou C., Rimbach G., Moini H., et al. Solar ultraviolet- induced erythema in human skin and nuclear factor- kappa- B dependent gene expression in keratinocytes are modulated by a French maritime pine bark extract. Free Radic Biol Med 30 (2001) 154-160
36. Ni A., Mu Y., and Gulati O. Treatment of melasma with pycnogenol. Phytother Res 16 (2007) 567-571
37. Katiyar S.K., Korman N.J., Mukhtar H., et al. Protective effects of silymarin against photocarcinogenesis in a mouse skin model. J Natl Cancer Inst 89 (1997) 556-566
38. Draelos Z.D. Cosmeceutical botanicals: part 1. In: Draelos Z.D. (Ed). Cosmeceuticals (2005), Elsevier Saunders, Philadelphia 71-78
39. Katsarou A., Davoy E., Xenos K., et al. Effect of an antioxidant (quercetin) on sodium- lauryl- sulfate-induced skin irritation. Contact Dermatitis 42 (2000) 85-89
40. Bhatia N., Agarwal C., and Agarwal R. Differential responses of skin cancer-chemopreventive agents silibinin, quercetin, and epigallocatechin 3-gallate on mitogenic signaling and cell cycle regulators in human epidermoid carcinoma A431 cells. Nutr Cancer 39 (2001) 292-299
41. Draelos Z.D. Cosmeceuticals and sensitive skin. Cosmet Dermatol 18 (2005) 764-767
42. Thornfeldt C. Cosmeceuticals containing herbs: fact, fiction, and future. Dermatol Surg 31 (2005) 873-880
43. Yarnell E., Absacol K., and Hooper C.G. Clinical botanical medicine (2002), Mary Ann Liebert, Larchmont, NY
44. Baumann L.S., Eichenfeld L.F., and Taylor S.C. Advancing the science of naturals. Cosmet Dermatol 18 suppl (2004) 2-8
45. Ditre C.M. Exfoliants: AHAs and BHAs. In: Draelos Z.D. (Ed). Cosmeceuticals (2005), Elsevier Saunders, Philadelphia 111-118
46. Berardesca E., Distante F., Vignoli G.P., et al. Alpha hydroxyacids modulate stratum corneum barrier function. Br J Dermatol 137 (1997) 934-938
47. Bernstein E.F., Brown D.B., Schwartz M.D., et al. The polyhydroxy acid gluconolactone protects against ultraviolet radiation in an in vitro model of cutaneous photoaging. Dermatol Surg 30 (2004) 189-195
48. Grimes P.E., Green B.A., Wildnauer R.H., et al. The use of polyhydroxy acids (PHAs) in photoaged skin. Cutis 73 suppl (2004) 3-13
49. Rendon M.I., and Gaviria J.I. Review of skin- lightening agents. Dermatol Surg 317 (2005) 886-889
50. Niwa Y., and Akamatsu H. Kojic acid scavenges free radicals while potentiating leukocyte functions including free radical generation. Inflammation 15 (1991) 303-315
51. Nakagawa M., and Kawai K. Contact allergy to kojic acid in skin care products. Contact Dermatitis 32 (1995) 9-13
52. Yokota T., Nishio H., and Kubota Y. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res 11 (1998) 355-361
53. Briganti S., Camera E., and Picardo M. Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Res 16 (2003) 101-110
54. Draelos Z.D. Cosmeceutical trends: the multifunctional cosmetic. Cosmet Dermatol 17 (2004) 735-736